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1Medical Research Council, The Gambia Unit, Fajara, The Gambia; 2INDEPTH Network, Accra,
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Objective: To estimate and evaluate the cause-of-death structure and disease-specific mortality rates in a rural
area of The Gambia as determined using the InterVA-4 model.
Design: Deaths and person-years of observation were determined by age group for the population of the
Farafenni Health and Demographic Surveillance area from January 1998 to December 2007. Causes of
death were determined by verbal autopsy (VA) using the InterVA-4 model and ICD-10 disease classification.
Assigned causes of death were classified into six broad groups: infectious and parasitic diseases; cancers;
other non-communicable diseases; neonatal; maternal; and external causes. Poisson regression was used to
estimate age and disease-specific mortality rates, and likelihood ratio tests were used to determine statistical
significance.
Results: A total of 3,203 deaths were recorded and VA administered for 2,275 (71%). All-age mortality declined
from 15 per 1,000 person-years in 19982001 to 8 per 1,000 person-years in 20052007. Children aged 14 years
registered the most marked (74%) decline from 27 to 7 per 1,000 person-years. Communicable diseases
accounted for half (49.9%) of the deaths in all age groups, dominated by acute respiratory infections (ARI)
(13.7%), malaria (12.9%) and pulmonary tuberculosis (10.2%). The leading causes of death among infantswere
ARI (5.59 per 1,000 person-years [95%CI: 4.387.15]) andmalaria (4.11 per 1,000 person-years [95%CI: 3.09
5.47]). Mortality rates in children aged 14 years were 3.06 per 1,000 person-years (95% CI: 2.583.63) for
malaria, and 1.05 per 1,000 person-years (95% CI: 0.791.41) for ARI. The HIV-related mortality rate in this
age group was 1.17 per 1,000 person-years (95% CI: 0.891.54). Pulmonary tuberculosis and communicable
diseases other thanmalaria, HIV/AIDS andARI were the main killers of adults aged 15 years and over. Stroke-
related mortality increased to become the leading cause of death among the elderly aged 60 years or more in
20052007.
Conclusions: Mortality in the Farafenni HDSS area was dominated by communicable diseases. Malaria and
ARI were the leading causes of death in the general population. In addition to these, diarrhoeal disease was a
particularly important cause of death among children under 5 years of age, as was pulmonary tuberculosis
among adults aged 15 years and above.
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T
he development of a successful health care system
should be supported by information on the fre-
quency of specific diseases and their contribution
to morbidity and mortality in the population. Therefore,
measuring mortality, including cause-of-death deter-
mination, enhances every level of health care planning,
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resource allocation and service delivery systems (1, 2).
Unfortunately, many countries with the greatest demand
for this information have weak health systems that do not
generate the requisite information to establish cause-of-
death distributions (3, 4) as they also lack functional vital
registration systems to capture all the deaths in their
populations at specific periods (5). This is particularly
true for sub-Saharan Africa where the majority of deaths
occur at home with little or no chance of the cause of
death being certified by qualified medical personnel.
In this context, verbal autopsy (VA), despite its known
limitations, is the most viable option for generating re-
presentative cause-of-death information.
The VA approach to determination of the cause of death
is described in detail elsewhere (5). Used predominantly
in research settings, the range of methods adopted for
cause-of-death assignment includes physician-certification,
data-derived algorithms, application of Bayes’ theorem,
and direct statistical estimation of cause fractions (2).
Physician-certified VA (PCVA) is an established method
for assigning cause of death, but it is time consuming.
Different approaches more suitable for resource-challenged
settings have been developed (6). These include the
InterVA, a computer-based automated VA coding model,
and the adoption by WHO of a set of standardised
questionnaires that facilitate comparison across different
geographical and environmental settings (7). InterVA
has been validated in different settings throughout its
evolution (811).
The Gambia, like many other low-income countries,
does not have a functional civil and vital registration
system. Health facilities are also unable to provide such
information. The only available information on causes
of death derives from studies focused on specific target
groups (mainly children aged under 5 years) (1214) and
from a hospital-based study in Banjul, representing a
largely urban area (15). There are no data on the cause-
of-death structure and its evolution over time at the
national or sub-national level. However, relevant data
have been collected routinely in a population of about
45,000 people in the town of Farafenni and its environs in
the North Bank Region of The Gambia as part of the
Farafenni Health and Demographic Surveillance System
(HDSS). VAs conducted for deaths that occurred be-
tween 1998 and 2007 were used to evaluate the cause-
of-death patterns and to establish the disease-specific
mortality burdens for this part of The Gambia.
Methods
Study area
The Farafenni HDSS was established in the North Bank
Region of The Gambia in 1981 in two geographically
contiguous clusters of 42 rural villages to the east and
west of the town of Farafenni (population 25,000). In
October 2002, the surveillance area was expanded to
include Farafenni Town and 23 settlements within a 5-km
radius of the town (see Fig. 1). The majority of the
residents are subsistence farmers with very few earning
salaries from employment. Detailed socio-demographic
characteristics of the population are described elsewhere
(13).
Malaria transmission is highly seasonal with most
infections occurring between September and November.
It was highly endemic in the past but has now declined
substantially (16). The health care system consists of an
under-resourced village-based primary health care system
that has been operational since 1983 made up of 16 PHC
Posts and five Dispensaries, a Health Centre for repro-
ductive and child health services, and a 250-bed referral
district hospital in the town of Farafenni, which was
commissioned in 1999. Immunisation coverage levels for
individual vaccines against childhood diseases are high
(17), and use of ITNs is widespread (18). For the period
20002001, HIV prevalence among pregnant women in
The Gambia was 1.0% for HIV-1 and 0.8% for HIV-2,
and the corresponding levels for Farafenni were 0.4 and
0.3%, respectively (19). From a similar sentinel surveil-
lance in 2008, the national prevalence levels were 1.6% for
HIV1 and 0.4% for HIV2 (20). The majority of deaths
occur at home and burials are held almost immediately
or within a few hours after death, in line with religious
beliefs. This constitutes a barrier to having deaths medi-
cally certified or being captured by vital registration.
Data and statistical analysis
The surveillance procedures of the Farafenni HDSS are
described in detail elsewhere (13, 21). The administration
of VAs was introduced in 1998 for a sample of deaths and
for specific study purposes. Routine administration of VA
for every death in the area using the 2002 standard WHO
VA questionnaires for neonates, children and adults
commenced in 2005. VAs were administered retrospec-
tively for deaths that occurred before 2005. VA interviews
are conducted at least 40 days after death by trained
fieldworkers, but the time lapse between death and inter-
view has spanned up to 3 years in some cases. The main
carers of the deceased persons prior to their deaths are
targeted for the interviews, or if they are not available,
other close relatives who were present during the period
of illness and death. Interviews were conducted in one of
the three main local languages spoken in the area.
The data collected using the three different age-specific
questionnaires have been systematically transformed into
the InterVA-4 input format and merged together. Re-
sponses for questions in the InterVA-4 format that could
not be derived from the original data were coded as
missing. InterVA-4 was applied with malaria prevalence
set as ‘high’ and HIV prevalence as ‘low’, reflecting the
situation in the study area for the period covered by this
Momodou Jasseh et al.
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study and as recommended for West African regions.
The data forms part of the INDEPTH Network pooled
dataset for cause-of-death analyses covering Farafenni
HDSS and 21 other INDEPTH HDSS sites (22).
The assigned causes of death were classified into six
broad groups: infectious and parasitic diseases, cancers,
other non-communicable diseases, neonatal, maternal,
and external causes. In the analysis presented here, cause-
specific mortality fractions (CSMFs) are derived from the
three most likely causes of death and the residual indeter-
minate fraction assigned by InterVA-4 using disease
codes in version 10 of the International Statistical Classi-
fication of Diseases and Related Health Problems, ICD-
10. The output was merged with the detailed individual
level data and analysed using STATA version 12 (Stata
Corporation, College Station, TX, USA). Cause-specific
mortality rates were calculated as the number of cause-
specific deaths per 1,000 person-years of follow-up. They
were derived using survival analysis techniques and
Poisson regression, and individual deaths were associated
with the most likely cause of death. Statistical signifi-
cance at the 95% confidence level was determined using
likelihood ratio tests. Since annual cause-specific mortal-
ity rates would not be meaningful due to small numbers
of cause-specific deaths, the study period was divided up
into three short periods with roughly similar numbers of
deaths for the assessment of cause-specific mortality
trends. These were defined a priori as 19982001, 2002
2004, and 20052007.
The Joint MRC/Gambia Government Ethics commit-
tee approved the establishment of the Farafenni HDSS
and all instruments used to collect household and indi-
vidual level information, including the VA questionnaires.
Verbal consent was obtained for the administration of all
VA questionnaires.
Results
The mid-year population of the Farafenni HDSS in 1998
was 15,960 with a mean age of 23.0 years; and 44,644
in 2007 with a mean age 22.4 years. The age structure
remained the same with 18% of the population aged less
than 5 years in both periods; whilst the proportion aged 15
years and over was 53% in 1998 and 55% in 2007. Between
1 January 1998 and 31 December 2007, 3,203 deaths were
recorded and VAs were administered for 2,275 (71%) of
them. Annual VA coverage improved progressively from
about 50% in the first 3 years of the study period and
peaked at 87% in 2003. Coverage was generally high
among adults aged 15 years or more throughout the study
period. There was no difference in VA coverage by gender
or area of residence.
Overall mortality declined by a third in the rural part of
the demographic surveillance area over the 10-year period,
a decline from 15 per 1,000 person-years in 19982001 to
Fig. 1. Location of the urban and contiguous rural areas east and west of Farafenni Town, which collectively constitute the
Farafenni Health and Demographic Surveillance area.
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10 per 1,000 person-years in 20052007 and by 12.5%
in the urban part between 20022004 and 20052007,
a decline from 8 to 7 per 1,000 person-years (Table 1).
Mortality dropped by 55% among infants (from 78 to 35
per 1,000 person-years) and by 74% among children 14
years old (from 27 to 7 per 1,000 person-years). Overall
mortality rates did not vary appreciably between ethnic
groups in anyof the three periods; and females had a lower
mortality rate than males throughout.
CSMFs generated by InterVA-4 are presented in
Table 2 by age group, sex, area of residence and ethnicity.
Almost half (49.9%) of deaths over the 10-year period
were attributed to communicable diseases. These were
dominated by acute respiratory infections (ARI) (13.7%),
malaria (12.9%) and pulmonary tuberculosis (10.2%).
A similar pattern of cause-specific mortality proportions
was maintained in all three periods. However, the pro-
portion of HIV-related deaths showed an increasing trend
over the three periods.
Malaria, ARI and diarrhoeal diseases accounted for
more than half (58.5%) of deaths among children aged
under 5 years (Fig. 2); 11% of deaths were attributed to
HIV-related causes in this age group. More than a third
(38%) of deaths among those aged 1559 years were due
to four communicable diseases: pulmonary tuberculosis
(14%), ARI (including pneumonia) (9.9%), malaria
(7.5%) and HIV/AIDS (6.5%). Overall, 46 and 37.8% of
adult deaths were attributed to communicable and non-
communicable diseases respectively.
Table 3 shows the top five cause-specific mortality rates
for each age group and period. Overall, ARI, malaria,
diarrhoeal diseases, neonatal sepsis, HIV/AIDS-related
illnesses and severe malnutrition had the highest cause-
specific mortality rates among children under 5 years of
age. ARI mortality was consistently high among infants
throughout the study period with an average rate of 5.59
per 1,000 person-years (95% CI: 4.387.15), followed by
malaria with a rate of 4.11 per 1,000 person-years (95%
CI: 3.095.47). The reverse pattern was observed among
children aged 14 years who had a malaria mortality rate
of 3.06 per 1,000 person-years (95% CI: 2.583.63) and
an ARI mortality rate of 1.05 per 1,000 person-years
(95% CI: 0.791.41). HIV-related mortality had the
second highest rate in this age group (1.17 per 1,000
person-years [95% CI: 0.891.54]). Disease-specific mor-
tality rates among children aged under 5 years increased
overall between 19982001 and 20022004 due to in-
creased VA coverage, but only significantly for malaria
in infants (p0.001) and children 14 years (pB0.0001).
Although at comparatively lower levels, malaria, ARI,
acute abdomen and HIV/AIDS constituted the greatest
mortality burden among older children aged 514 years.
Pulmonary tuberculosis, ARI, malaria and other infec-
tious diseases (i.e. communicable diseases other than
those listed in Table 2) were the main causes of death
among adults aged 1559 years. Maternity-related causes
also had a relatively high mortality burden among
women of reproductive age (1549 years) (mortality rate
of 0.36 per 1,000 person-years [95% CI: 0.280.47]).
Overall, pulmonary tuberculosis and other infectious
diseases were the main causes of death of adults in the
Farafenni area during the 10-year period, each with a
disease-specific mortality rate of 0.68 per 1,000 person-
years (95% CI: 0.570.83). There was no significant
change in their respective mortality rates in the latter
two periods compared to the first (p0.567 for 2002
2004 and 0.703 for 20052007 for TB; and p0.276 and
0.885 for other infectious diseases for the same periods).
Pulmonary tuberculosis and other infectious diseases,
stroke, ARI and malaria were the main causes of death
among the elderly population aged 60 years and over.
Mortality from stroke emerged in the last 6 years of the
study period as the most important cause of death in this
age group  9.62 per 1,000 person-years in 20022004
(95% CI: 7.4512.00) and 6.32 per 1,000 person-years in
20052008 (95% CI: 4.698.52).
The mortality burdens of both communicable and
non-communicable diseases are summarised in Table 4 by
period, age group, sex, ethnicity and area of residence.
Mortality rates for both categories of disease dropped
significantly in 20052007 compared with levels in 1998
2001. For all categories of disease, mortality burdens
were greater in the rural than in the urban area. Males
had a 42% (95% CI: 2759%) and a 26% (95% CI:
947%) higher risk of dying from communicable and
non-communicable diseases respectively compared to
females. Mandinkas were more likely to die from a non-
communicable disease than any other ethnic group (RR
1.45, 95% CI: 1.221.71). Cancer-related mortality was
significantly higher among men than women (RR 1.66,
95% CI: 1.292.15) and among rural rather than urban
residents (RR 1.73, 95% CI: 1.332.26). Only cancers
arising from the reproductive system were more prevalent
among females than males.
Discussion
There has been an appreciable decline in all-cause mor-
tality in the Farafenni HDSS area over the 10-year period
considered in this study. However, the pace of decline
varied markedly between different age groups. Reduction
in childhood mortality, especially among children aged
between 1 and 4 years, accounted for much of the overall
decline, similar to other countries in sub-Saharan Africa
(23, 24). Improvements in the death rates for adults and
the elderly were very modest.
With respect to causes of death, the results presented
here give the first indication of the cause-specific pattern
of mortality for all age groups over a period of time for
any geographically defined population in The Gambia.
Previous ad hoc investigations in the Farafenni HDSS
Momodou Jasseh et al.
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Table 1. Number of deaths, proportion of deaths with verbal autopsy and death rates by period and population
All 19982001 20022004 20052007
No. of
deaths
Number of VAs
conducted (% of
deaths)
Death rate
(per 1,000
PY)
No. of
deaths
Number of VAs
conducted (% of
deaths)
Death rate
(per 1,000
PY)
No. of
deaths
Number of VAs
conducted (% of
deaths)
Death rate
(per 1,000 PY)
No. of
deaths
Number of VAs
conducted (% of
deaths)
Death rate
(per 1,000
PY)
Age group
B1 year 536 224 (42) 47 201 20 (10) 78 162 122 (75) 42 173 82 (47) 35
14 years 559 295 (53) 13 246 24 (10) 27 188 163 (87) 12 125 108 (86) 7
514 years 204 137 (67) 2 81 38 (47) 4 67 59 (88) 2 56 40 (71) 2
1559
years
891 715 (80) 6 187 180 (96) 6 368 303 (82) 6 336 232 (69) 5
60 years 1,013 904 (89) 58 287 280 (98) 63 359 331 (92) 59 367 293 (80) 54
Sex
Male 1,727 1,217 (70) 12 531 287 (54) 17 609 522 (86) 11 587 408 (70) 9
Female 1,476 1,058 (72) 9 471 255 (54) 14 535 456 (85) 9 470 347 (74) 7
Ethnic group
Wollof 1,192 825 (69) 10 349 172 (49) 15 418 355 (85) 9 425 298 (70) 8
Mandinka 1,262 950 (75) 11 453 272 (60) 16 428 386 (90) 11 381 292 (77) 9
Fula 629 416 (66) 9 194 95 (49) 14 239 195 (82) 10 196 126 (64) 7
Other 120 84 (70) 7 6 3 (50) 9 59 42 (71) 8 55 39 (71) 6
Area of
residence
Rural 2,145 1,491 (70) 13 1,002 542 (54) 15 635 572 (90) 12 508 377 (74) 10
Urbana 1,058 784 (74) 7 509 406 (80) 8 549 378 (69) 7
All 3,203 2,275 (71) 10 1,002 542 (54) 15 1,144 978 (85) 10 1,057 755 (71) 8
aSurveillance in this area started in October 2002.
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Table 2. Cause-specific mortality fractions (CSMFs) derived using recommended InterVA-4 settings by age group, period, sex, residence and ethnicity
Classification and
causes of death Total
B1
year
14
years
514
years
1559
years
60
years 19982001 20022004 20052007 Male Female Rural Urban Wollof Mandinka Fula Other
Number of deaths 2,275 224 295 137 715 904 542 978 755 1,217 1,058 1,491 784 825 950 416 84
Infectious diseases
Malaria 12.9 15.8 38.3 28.3 7.5 5.9 10.7 14 12.9 12.3 13.5 13 12.6 15.4 10.3 13.5 13.9
ARI, including
pneumonia
13.7 28.1 15.2 11.7 9.9 12.9 13.5 13.8 13.6 15 12.2 14 13 14.5 13.1 13.8 11.3
Pulmonary
tuberculosis
10.2 0.4 1 14 14.3 10.2 9.7 10.8 12.6 7.4 9.6 11.3 7.4 12.5 8.8 17.5
HIV/AIDS-related 5.8 5.9 15 8.7 6.6 1.9 3.3 6.2 7.2 4.3 7.6 4.8 7.8 6.5 4.5 7.3 8
Diarrhoeal diseases 3.9 10.2 8.3 0.9 3.7 1.7 4.2 3.8 3.9 4 3.8 4.3 3.3 3.4 4.2 4.7 2.1
Meningitis and
encephalitis
2.2 1.5 1.3 6.5 2.7 1.5 3 1.8 2 2.1 2.2 2.1 2.2 2.5 1.4 2.8 4.2
Other infectious
diseases
1.2 0.1 0.1 2.8 1.6 1.2 1.1 1.4 1 1.7 0.6 1.2 1.2 0.9 1.2 1.6 0.7
Cancers
Digestive neoplasms 3.1 5.3 3.5 3 3 3.3 3.6 2.5 2.8 3.6 3.1 3.1 3.4 1.1
Respiratory
neoplasms
1.6 1.6 2.7 2.3 1.5 1.3 2.4 0.7 1.8 1.3 0.8 2.2 1.5 3.3
Reproductive
neoplasms
1.3 1.6 2.1 1.8 1.3 1 1 1.7 1.4 1.1 1.3 1.4 1.2 0.9
Other neoplasms 0.9 3.2 3.8 3 2.4 2.3 2.7 2.3 2.5 2.5 2.4 2.9 1.9 2.3
Other NCDs
Stroke 6.4 4.2 12.8 5.6 6.8 6.5 5.4 7.6 5.9 7.5 5.9 6.4 7.6 6.3
Acute abdomen 4.8 0.4 0.2 9.7 5.6 6 6.5 3.9 4.8 4.5 5.1 5 4.5 4.2 6.2 3.2 3.4
Severe malnutrition 1.6 3.4 6 1.5 0.2 0.8 0.8 1.7 2.1 1.6 1.5 1.5 1.9 2.1 1.4 1.3 0.9
Acute cardiac
diseases
0.9 0.8 1.5 1 0.6 1 0.8 0.9 0.9 0.8 1.3 0.7 0.5
Other cardiac
diseases
1.3 0.5 0.8 2.2 1.1 1.7 1 1.5 1.4 1.3 1.3 1 2 1.6 1.2 1.1 1
Other unspecified
NCDs
2.5 0.1 0.8 1.2 3 3.5 2.5 2.2 3 2.2 2.9 2.6 2.3 2.4 3.1 2
Liver cirrhosis 2.5 1.8 0.8 1.3 0.5 0.9 1.1 1.1 0.7 1.1 0.6 1 0.5 1.6 1.2
Neonatal 2 20.6 1.4 3.2 0.9 1.5 2.6 2.9 0.4 2.1 2.1 1.6 2.4
External 2.5 0.7 1.2 5.9 3.8 1.7 2.9 2.1 2.6 2.7 2.2 2.4 2.5 2.2 2.9 2.2 1.8
Maternal 2.1 6.8 2.6 2.3 1.5 4.6 2 2.4 2.7 1.5 2.4 2.9
Indeterminate 16.6 12.8 12.4 17.8 16.2 19.1 19.1 15.9 15.8 17.1 16 17.3 15.3 16.5 17.2 16 14.7
Total 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
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area and other parts of the country used the physician
coding method of VAs and focused on populations of
interest such as children (12, 13, 25), women of repro-
ductive age (26), or hospital patients (15). The outcomes
of this study are therefore relevant from two perspectives.
First, it provides an opportunity to evaluate the cause-of-
death structure produced by the InterVA-4 model against
the established disease epidemiology of the region and
secondly it helps in defining the public health priorities of
the area.
Using the recommended settings for malaria and HIV
prevalence levels in West Africa, InterVA-4 has produced
results that suggest three preventable and treatable dis-
eases accounted for more than half (58%) of all deaths
among children aged under 5 years between 1998 and 2007.
These were malaria (28%), ARI (21%) and diarrhoeal
diseases (9%) (Fig. 2). These proportions compare rea-
sonably well with the distribution of under-5 deaths in
2008 estimated for The Gambia by the Child Health
Epidemiology Reference Group (CHERG), with 53% of
under-5 deaths being attributed to malaria, pneumonia
and diarrhoeal diseases (27). These three diseases also
dominate the overall cause-of-death structure compiled
for children aged under 5 years in sub-Saharan Africa
(27, 28). A similar study in Niakhar in central Senegal
about 150 km north of the Farafenni HDSS, showed the
same pattern of mortality burden among children under 5
years old for these three specific diseases (29), although
malaria cases were included in a broader classification of
fevers of unknown origin.
The InterVA-4 results suggest that only about one-
tenth (9%) of under-5 deaths were due to neonatal causes,
substantially lower than the CHERG estimate of 27%
for The Gambia (Fig. 2). This is likely to be due to the
relatively low VA coverage for infants during the study
period; only a quarter (51/199) of neonatal deaths had a
VA administered. Assuming that all neonatal deaths were
due to neonatal causes, this will increase the proportion
of under-5 deaths due to neonatal causes to 30%, which is
similar to the CHERG estimate.
In viewof the relatively lowHIV prevalence in Farafenni,
InterVA appears to have overestimated the proportion of
under-5 deaths from HIV/AIDS, ranking it as the second
highest killer among children aged 14 years (Table 3).
Malnutrition is prevalent in rural Gambia and constitutes
amajor public health concern. About a quarter of children
aged less than 5 years in the North Bank Region of The
Gambia are underweight (18). It is therefore possible that
the InterVA-4 model misinterpreted symptoms of mal-
nourishment in children and returned the cause of their
deaths as HIV-related, thus overestimating deaths result-
ing from HIV/AIDS. A similar conclusion was reached
in another study in Kenya that compared the outcomes of
an earlier version of InterVA and physician coding of the
same VAs (11).
The plausibility of the cause-specific mortality pro-
portions for adults aged 1559 years was assessed by
Fig. 2. Comparison of the distribution of causes of death among children under 5 years of age by InterVA-4 for Farafenni
HDSS, 19982007 and CHERG estimates for The Gambia, 2008 (27).
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Table 3. Top five causes of death by age group and period
19982007 19982001 20022004 20052007
Age
group
and rank Cause
No. of
deaths
Cause-specific
mortality rate
per 1,000 PY
(95% CI) Cause
No. of
deaths
Cause-specific
mortality rate
per 1,000 PY
(95% CI) Cause
No. of
deaths
Cause-specific
mortality rate
per 1,000 PY
(95% CI) Cause
No. of
deaths
Cause-specific
mortality rate
per 1,000 PY
(95% CI)
B1 year
1 ARI, including
pneumonia
64 5.59 (4.387.15) Neonatal
sepsis
4 1.54 (0.584.11) ARI, including
pneumonia
36 9.34 (6.7413.00) ARI, including
pneumonia
25 5.01 (3.387.41)
2 Malaria 47 4.11 (3.095.47) Malaria 4 1.54 (0.584.11) Malaria 21 5.45 (3.558.36) Malaria 22 4.41 (2.906.69)
3 Neonatal
sepsis
31 2.71 (1.913.85) ARI, including
pneumonia
3 1.16 (0.373.59) Neonatal
Sepsis
21 5.45 (3.558.36) Diarrhoeal
diseases
10 2.00 (1.083.72)
4 Diarrhoeal
diseases
24 2.10 (1.413.13) Neonatal
pneumonia
2 0.77 (0.193.08) Diarrhoeal
diseases
12 3.11 (1.775.48) Neonatal
sepsis
6 1.20 (0.542.68)
5 HIV/AIDS-
related
14 1.22 (0.722.07) Other neonatal
causes
2 0.77 (0.193.08) Neonatal
pneumonia
9 2.33 (1.214.49) HIV/AIDS-
related
6 1.20 (0.542.68)
Indeterminate 11 Indeterminate 0 Indeterminate 7 Indeterminate 4
14 years
1 Malaria 131 3.06 (2.583.63) Malaria 16 1.78 (1.092.91) Malaria 78 4.92 (3.946.14) Malaria 37 2.06 (1.492.84)
2 HIV/AIDS-
related
50 1.17 (0.891.54) Diarrhoeal
diseases
2 0.22 (0.060.89) HIV/AIDS-
related
27 1.70 (1.172.48) HIV/AIDS-
related
23 1.28 (0.851.93)
3 ARI, including
pneumonia
45 1.05 (0.791.41) ARI, including
pneumonia
1 0.11 (0.020.79) ARI, including
pneumonia
25 1.58 (1.062.33) ARI, including
pneumonia
19 1.06 (0.671.66)
4 Diarrhoeal
diseases
26 0.61 (0.410.89) Severe
malnutrition
1 0.11 (0.020.79) Diarrhoeal
diseases
13 0.82 (0.481.41) Diarrhoeal
diseases
11 0.61 (0.341.11)
5 Severe
malnutrition
18 0.42 (0.260.67) Meningitis and
encephalitis
1 0.11 (0.020.79) Severe
malnutrition
7 0.44 (0.210.93) Severe
malnutrition
10 0.56 (0.301.03)
Indeterminate 9 Indeterminate 2 Indeterminate 4 Indeterminate 3
514 years
1 Malaria 47 0.53 (0.400.70) Malaria 11 0.58 (0.321.05) Malaria 25 0.76 (0.511.12) Malaria 11 0.30 (0.170.54)
2 ARI, including
pneumonia
16 0.18 (0.110.29) Acute
abdomen
6 0.32 (0.140.71) HIV/AIDS-
related
6 0.18 (0.080.41) ARI, including
pneumonia
6 0.16 (0.070.36)
3 Acute
abdomen
15 0.17 (0.100.28) ARI, including
pneumonia
6 0.32 (0.140.71) Acute
abdomen
6 0.18 (0.080.41) HIV/AIDS-
related
6 0.16 (0.070.36)
4 HIV/AIDS-
related
14 0.16 (0.090.27) External
causes
3 0.16 (0.050.49) ARI, including
pneumonia
4 0.12 (0.050.32) Acute
abdomen
3 0.08 (0.030.25)
5 External
causes
9 0.10 (0.050.19) Meningitis and
encephalitis
3 0.16 (0.050.49) External
causes
3 0.09 (0.030.28) Meningitis and
encephalitis
3 0.08 (0.030.25)
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Table 3 (Continued )
19982007 19982001 20022004 20052007
Age
group
and rank Cause
No. of
deaths
Cause-specific
mortality rate
per 1,000 PY
(95% CI) Cause
No. of
deaths
Cause-specific
mortality rate
per 1,000 PY
(95% CI) Cause
No. of
deaths
Cause-specific
mortality rate
per 1,000 PY
(95% CI) Cause
No. of
deaths
Cause-specific
mortality rate
per 1,000 PY
(95% CI)
Indeterminate 8 Indeterminate 3 Indeterminate 4 Indeterminate 1
1559 years
1 Pulmonary
tuberculosis
107 0.68 (0.570.83) ARI, including
pneumonia
23 0.76 (0.501.14) Pulmonary
tuberculosis
44 0.75 (0.561.01) Pulmonary
tuberculosis
44 0.65 (0.490.88)
2 Other
infectious
diseases
107 0.68 (0.570.83) Pulmonary
tuberculosis
19 0.62 (0.400.98) Other
infectious
diseases
44 0.75 (0.561.01) Other
infectious
diseases
44 0.65 (0.490.88)
3 ARI, including
pneumonia
78 0.50 (0.400.62) Other
infectious
diseases
19 0.62 (0.400.98) ARI, including
pneumonia
37 0.63 (0.460.87) Malaria 27 0.40 (0.270.58)
4 Malaria 61 0.39 (0.300.50) Maternal
causesa
18 0.59 (0.370.94) Maternal
causesa
25 0.43 (0.290.63) HIV/AIDS-
related
19 0.28 (0.180.44)
5 Maternal
causesa
56 0.36 (0.280.47) Acute
abdomen
15 0.49 (0.300.82) HIV/AIDS-
related
24 0.41 (0.280.61) ARI, including
pneumonia
18 0.27 (0.170.42)
Indeterminate 47 Indeterminate 9 Indeterminate 21 Indeterminate 17
60+ years
1 Pulmonary
tuberculosis
137 7.84 (6.639.27) ARI, including
pneumonia
47 10.00 (7.7914.00) Stroke 59 9.62 (7.4512.00) Stroke 43 6.32 (4.698.52)
2 Other
infectious
diseases
137 7.84 (6.639.27) Pulmonary
tuberculosis
43 9.49 (7.0413.00) Other
infectious
diseases
54 8.80 (6.7411.00) ARI, including
pneumonia
42 6.17 (4.568.35)
3 Stroke 134 7.67 (6.489.09) Other
infectious
diseases
43 9.49 (7.0413.00) Pulmonary
tuberculosis
54 8.80 (6.7411.00) Pulmonary
tuberculosis
40 5.88 (4.318.02)
4 ARI, including
pneumonia
130 7.44 (6.278.84) Stroke 32 7.06 (4.999.99) ARI, including
pneumonia
41 6.68 (4.929.08) Other
infectious
diseases
40 5.88 (4.318.02)
5 Malaria 63 3.61 (2.824.62) Malaria 24 5.30 (3.557.90) Acute
abdomen
20 3.26 (2.105.05) Acute
abdomen
24 3.53 (2.365.26)
Indeterminate 82 Indeterminate 28 Indeterminate 32 Indeterminate 22
aRate based on person-time contributed by women aged 1549 years who constitute the population at risk of maternal causes of death.
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re-grouping all causes by sex into the categories indicated
in Fig. 3 and comparing the resulting patterns of cause
and sex-specific mortality rates with those derived for the
African region as a whole in 2008 (28). Apart from dif-
ferences in the magnitudes of the burdens of HIV/AIDS
and external (including injury) mortality, the InterVA-
derived cause and sex-specific patterns of mortality
among adults in the Farafenni HDSS area are remarkably
similar to those of the African region. Common features
between the two sets of mortality patterns include higher
mortality rates among males for external, communicable
and non-communicable disease-related causes of death
and a higher HIV/AIDS mortality rate among females
than among males. Communicable diseases, especially
pulmonary tuberculosis, constitute the greatest mortality
burden among adults aged 1559 years in the Farafenni
HDSS area.
As expected, there were more deaths among the
elderly population aged 60 years and over, the group who
had the highest VA coverage (89%). However, in the
absence of an established cause-of-death structure for
the elderly in an epidemiological setting such as that of
the Farafenni HDSS, the plausibility of the disease-
specific mortality burdens in this age group cannot be
assessed with certainty. Judging from the reasonable
cause-of-death distributions obtained for children and
adults, and the fact that the InterVA-4 model has not
returned any unexpected or unreasonable cause or causes
of death in the elderly, the cause-of-death structure
obtained can be accepted as a reasonable reflection of
the pattern of mortality among the elderly in the area.
The results show that stroke has emerged as the leading
cause of death among this population in the latter part of
the period considered. The rise in cardiovascular risk
factors in this population to levels prevalent in the main
urban centre of The Gambia was established between
1996 and 1997 (30). Hence, the level of stroke mortality
produced by the model is plausible. Decreases in cause-
specific mortality rates for this age group were not
statistically significant and imply a stable cause-of-death
pattern over the study period.
Despite using VA data covering less than three-
quarters of all deaths in the period, especially among
children aged under 5 years, and transforming these data
from their original structure to meet InterVA-4 require-
ments, the model has proven useful in providing a
Table 4. Comparison of incidence of communicable and non-communicable diseases in the Farafenni demographic surveillance
area by period and socio-demographic characteristics
Non-communicable diseases
Communicable diseases All Cancers Others
Rate ratio
(95% CI) p
Rate ratio
(95% CI) p
Rate ratio
(95% CI) p
Rate ratio
(95% CI) p
Period
19982001 1 1 1 1
20022004 1.09 (0.941.25) 0.265 0.91 (0.751.10) 0.317 0.85 (0.621.16) 0.310 0.94 (0.741.19) 0.625
20052007 0.75 (0.640.87) B0.0001 0.67 (0.550.81) B0.0001 0.59 (0.430.82) 0.002 0.71 (0.550.90) 0.006
Age group
B1 year 1 1 1
14 years 0.45 (0.370.55) B0.0001 0.64 (0.311.34) 0.238 0.64 (0.311.34) 0.238
514 years 0.08 (0.060.10) B0.0001 0.34 (0.160.69) 0.003 0.30 (0.140.62) 0.001
1560 years 0.17 (0.140.21) B0.0001 1.64 (0.873.09) 0.126 1 0.90 (0.471.72) 0.750
60+ years 1.68 (1.402.03) B0.0001 26.85 (14.3450.28) B0.0001 12.31 (9.5315.91) B0.0001 17.75 (9.4433.36) B0.0001
Sex
Female 1 1 1 1
Male 1.42 (1.271.59) B0.0001 1.26 (1.091.47) 0.002 1.66 (1.292.15) B0.0001 1.09 (0.911.31) 0.359
Ethnic group
Wollof 1 1 1 1
Mandinka 1.18 (1.041.33) 0.012 1.45 (1.221.71) B0.0001 1.53 (1.152.05) 0.004 1.40 (1.141.72) 0.001
Fula 0.96 (0.821.12) 0.615 0.87 (0.701.09) 0.235 1.07 (0.741.53) 0.728 0.78 (0.591.03) 0.085
Other 0.84 (0.641.11) 0.232 0.56 (0.350.89) 0.015 0.82 (0.411.63) 0.562 0.44 (0.230.83) 0.011
Area of
residence
Urban 1 1 1 1
Rural 1.59 (1.421.79) B0.0001 1.56 (1.331.82) B0.0001 1.73 (1.332.26) B0.0001 1.47 (1.221.78) B0.0001
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population-based cause-of-death structure and disease-
specific mortality rates for a sub-national population
of The Gambia. The derived cause-specific mortality
rates should be interpreted as the minimal possible rates
because verbal autopsies were not administered for 29%
of the deaths considered in the study, especially among
children aged less than 5 years. In its Health Policy docu-
ment for the period 20122020, The Gambia govern-
ment identified the main causes of death in the country,
albeit without strong supporting evidence, as malaria,
pneumonia, anaemia, diarrhoeal diseases, road traffic
accidents, pregnancy complications and cardiovascular
diseases (20). Concern was also expressed over the increas-
ing incidences of tuberculosis and HIV/AIDS. The
results of this study reflect the same pattern of disease-
specific mortality burden in the Farafenni HDSS area,
and confirm the double burden of communicable and
non-communicable diseases, which constitute a huge
strain on a relatively weak local health care delivery
system.
The InterVA-4 model should be subjected to further
methodological tests and fine tuning to enhance its per-
formance in an epidemiologically dynamic setting like
that of the Farafenni HDSS area. Whilst an earlier study
confirmed that the model is capable of detecting a
significant epidemic of HIV-related mortality in South
Africa (31), and that the use of VA tracked effectively an
epidemiological transition in rural India (32), it has not
been sufficiently validated in settings with changing
malaria epidemiology and lower HIV prevalence than the
regional level prescribed by the model. With the recent
decline in malaria incidence in The Gambia (16, 33), a
comparison of the results obtained from this study with
those generated by setting the HIV and malaria pre-
valence levels that reflect the current epidemiological
situation will show the extent to which death from com-
municable diseases will be redistributed. Non-communicable
disease-related deaths will not be affected. The outcome
of such a comparison will identify and document poten-
tial methodological limitations of the model in an envi-
ronment like the Farafenni HDSS and facilitate future
enhancement of the model.
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